- Approval Id
- 9ad8a1c2ac7e6ae7
- Drug Approval Philippines Name
- Boostrix
- Product Name
- Boostrix
- Registration Number
- BR-1148
- Brand Name
- Boostrix
- Generic Name
- Combined Diphtheria, Tetanus, Acellular Pertussis Vaccine, Adsorbed
- Dosage Form
- Suspension For Injection (I.M.)
- Dosage Strength
- Formulation: 1 dose (0.5 mL) contains:
Diphtheria toxoid*-Not less than 2 IU (2.5Lf) Tetanus toxoid*-Not less than 20 IU (5Lf) Pertussis toxoid (PT)*-8mcg Filamentous Hemagglutinin (FHA)*-8mcg Pertactin-2.5mcg *adsorbed on Aluminum hydroxide, hydrated (Al(OH)3)-300 mcg Al3 and Aluminum phosphate (AlPO4)-200 mcg A13+
- Manufacturer
- GlaxoSmithKline Biologicals SA
- Importer
- GlaxoSmithKline Philippines, Inc.
- Company Detail Path
- /organization/glaxosmithkline-biologicals-sa
- Issuance Date
- 27 April 2021
- Expiry Date
- 03 June 2026
- Pharmacologic Category
- Vaccine
- Classification
- Prescription Drug (RX)
